+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alpha Tau Medical Ltd - Product Pipeline Analysis, 2021 Update

  • ID: 5367385
  • Company Profile
  • June 2021
  • 45 pages
  • GlobalData

FEATURED COMPANIES

  • Fore Biotherapeutics Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Alpha Tau Medical Ltd (Alpha Tau) is medical technology company that focuses on the discovery, development and marketing of Alpha DaRT (diffusing alpha-emitters radiation therapy) seed for the treatment of solid cancers. The company is evaluating Alpha DaRT therapy for the treatment of skin cancer, oral cavity cancer, head-and-neck cancer and breast cancer in clinical studies. It is advancing its clinical trials at cancer centers in Canada, Israel, Japan, Russia and France. The company is also investigating DaRT in pre-clinical trials as a combination with chemotherapy to combat local and metastatic cancer. Alpha Tau Medical is headquartered in Tel Aviv, Israel

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Alpha Tau Medical Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Fore Biotherapeutics Inc
  • MORE
Alpha Tau Medical Ltd Company Overview
  • Alpha Tau Medical Ltd Company Snapshot
  • Alpha Tau Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Alpha Tau Medical Ltd - Pipeline Analysis Overview
  • Alpha Tau Medical Ltd - Key Facts
  • Alpha Tau Medical Ltd - Major Products and Services
  • Alpha Tau Medical Ltd Pipeline Products by Development Stage
  • Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
Alpha Tau Medical Ltd Pipeline Products Overview
  • Alpha DaRT Kit - Breast cancer
  • Alpha DaRT Kit - Breast cancer Product Overview
  • Alpha DaRT Kit - Breast cancer Clinical Trial
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia Product Overview
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia Clinical Trial
  • Alpha DaRT Kit - Head and Neck Cancer
  • Alpha DaRT Kit - Head and Neck Cancer Product Overview
  • Alpha DaRT Kit - Neoadjuvant Rectal Cancer
  • Alpha DaRT Kit - Neoadjuvant Rectal Cancer Product Overview
  • Alpha DaRT Kit - Pancreatic Cancer
  • Alpha DaRT Kit - Pancreatic Cancer Product Overview
  • Alpha DaRT Kit - Pancreatic Cancer Clinical Trial
  • Alpha DaRT Kit - Prostate Cancer
  • Alpha DaRT Kit - Prostate Cancer Product Overview
  • Alpha DaRT Kit - Recurrent Cervical Cancer
  • Alpha DaRT Kit - Recurrent Cervical Cancer Product Overview
  • Alpha DaRT Kit - Recurrent Gynecological Cancer
  • Alpha DaRT Kit - Recurrent Gynecological Cancer Product Overview
  • Alpha DaRT Kit - Recurrent Prostate Cancer
  • Alpha DaRT Kit - Recurrent Prostate Cancer Product Overview
  • Alpha DaRT Kit - Recurrent Rectal Cancer
  • Alpha DaRT Kit - Recurrent Rectal Cancer Product Overview
  • Alpha DaRT Kit - Sarcoma
  • Alpha DaRT Kit - Sarcoma Product Overview
  • Alpha DaRT Kit - Sarcoma Clinical Trial
  • Alpha DaRT Kit - Squamous Cell Carcinoma
  • Alpha DaRT Kit - Squamous Cell Carcinoma Product Overview
  • Alpha DaRT Kit - Vulva Cancer
  • Alpha DaRT Kit - Vulva Cancer Product Overview
  • Alpha DaRT Kit - Vulva Cancer Clinical Trial
Alpha Tau Medical Ltd - Key Competitors

Alpha Tau Medical Ltd - Key Employees

Alpha Tau Medical Ltd - Locations and Subsidiaries
  • Head Office
Recent Developments
  • Alpha Tau Medical Ltd, Recent Developments
  • Feb 24, 2020: The introduction of Alpha Dart in Russia for treatment of metastatic breast cancer
  • Nov 26, 2019: Alpha Tau announces the publication of exceptional clinical data from Alpha DaRT, its novel alpha radiotherapy for solid tumors
  • Apr 11, 2019: Breakthrough cancer therapy developer, Alpha Tau, awarded ISO 13485 certificate for quality management of medical devices
  • Nov 07, 2018: Alpha Tau Medical launches new clinical trials in Italy with leading cancer centers, La Sapienza and IFO
  • Aug 21, 2018: Alpha Tau''s high-precision cancer radiotherapy receives radioactive-safety approval in the United States
  • Jan 03, 2018: Alpha Tau Medical Selected to Present at the Biotech Showcase 2018
  • Oct 30, 2017: Alpha Tau Medical initiates first clinical trial in Italy to treat cancer with Alpha Radiation
  • Jan 12, 2017: First clinical trials started in Israel
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Alpha Tau Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Alpha Tau Medical Ltd Pipeline Products by Equipment Type
  • Alpha Tau Medical Ltd Pipeline Products by Indication
  • Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
  • Alpha Tau Medical Ltd, Key Facts
  • Alpha Tau Medical Ltd, Major Products and Services
  • Alpha Tau Medical Ltd Number of Pipeline Products by Development Stage
  • Alpha Tau Medical Ltd Pipeline Products Summary by Development Stage
  • Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
  • Alpha Tau Medical Ltd Ongoing Clinical Trials Summary
  • Alpha DaRT Kit - Breast cancer - Product Status
  • Alpha DaRT Kit - Breast cancer - Product Description
  • Alpha DaRT Kit - Breast cancer - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Newly Diagnosed Breast Carcinoma Patients with Distant Metastases
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - Product Status
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - Product Description
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous Tumors
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
  • Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Preliminary Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters on Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia
  • Alpha DaRT Kit - Head and Neck Cancer - Product Status
  • Alpha DaRT Kit - Head and Neck Cancer - Product Description
  • Alpha DaRT Kit - Neoadjuvant Rectal Cancer - Product Status
  • Alpha DaRT Kit - Neoadjuvant Rectal Cancer - Product Description
  • Alpha DaRT Kit - Pancreatic Cancer - Product Status
  • Alpha DaRT Kit - Pancreatic Cancer - Product Description
  • Alpha DaRT Kit - Pancreatic Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
  • Alpha DaRT Kit - Prostate Cancer - Product Status
  • Alpha DaRT Kit - Prostate Cancer - Product Description
  • Alpha DaRT Kit - Recurrent Cervical Cancer - Product Status
  • Alpha DaRT Kit - Recurrent Cervical Cancer - Product Description
  • Alpha DaRT Kit - Recurrent Gynecological Cancer - Product Status
  • Alpha DaRT Kit - Recurrent Gynecological Cancer - Product Description
  • Alpha DaRT Kit - Recurrent Prostate Cancer - Product Status
  • Alpha DaRT Kit - Recurrent Prostate Cancer - Product Description
  • Alpha DaRT Kit - Recurrent Rectal Cancer - Product Status
  • Alpha DaRT Kit - Recurrent Rectal Cancer - Product Description
  • Alpha DaRT Kit - Sarcoma - Product Status
  • Alpha DaRT Kit - Sarcoma - Product Description
  • Alpha DaRT Kit - Sarcoma - A Pilot Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin and Superficial Soft Tissue Tumors
  • Alpha DaRT Kit - Squamous Cell Carcinoma - Product Status
  • Alpha DaRT Kit - Squamous Cell Carcinoma - Product Description
  • Alpha DaRT Kit - Vulva Cancer - Product Status
  • Alpha DaRT Kit - Vulva Cancer - Product Description
  • Alpha DaRT Kit - Vulva Cancer - A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters (DaRT) for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva
Alpha Tau Medical Ltd, Key Employees
  • Glossary
List of Figures
  • Alpha Tau Medical Ltd Pipeline Products by Equipment Type
  • Alpha Tau Medical Ltd Pipeline Products by Development Stage
  • Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Champions Oncology (Israel) Limited
  • Technion Technology Transfer
  • Fore Biotherapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll